Category Archives: Flibanserin
“Women with low libidos ‘have different brains’”
Tweet * If you ever wanted to see how the media simultaneously loves and destroys stories on sex and science, this week we had a classic example of truly bad sex coverage. All based on a conference presentation that suggested low libido in women could be detected through brain scanning. I’ll move on to the [...]
Also posted in Activism and Open Access, Bad science, Female Sexual Dysfunction Comments closed
FDA advisory panel rejects Flibanserin
TweetLast Friday drug company Boehringer Ingelheim presented evidence to the FDA’s advisory panel on their drug Flibanserin. This product, designed to tackle Hypoactive Sexual Desire Disorder (HSDD) in women had already been given plenty of media coverage focusing on ‘Pink Viagra’, and raised concern from scientists, healthcare staff, therapists and activists. You can see a [...]
Also posted in Activism and Open Access, Commercialisation, Female Sexual Dysfunction Comments closed
Is low sexual desire in women a disease? No it’s not. But drug company are seeking FDA approval for a drug to ‘cure’ women nonetheless
TweetOn June 18th pharmaceutical company Boehringer Ingelheim will be seeking approval from the Food and Drug Administration (FDA) for their drug Flibanserin (which may be traded under the names of Ectris and/or Girosa). This is an antidepressant style drug which Boehringer Ingelheim claim is a treatment for low/lack of sexual desire in women (aka Hypoactive [...]
Also posted in Activism and Open Access, Female Sexual Dysfunction, Intrinsa, Medicalisation Comments closed
Am I bovvered…about not desiring sex?
A drug company has launched a new study and patient registry to measure female sexual problems. Using a five question quick checklist you can now be diagnosed as dysfunctional.
Also posted in Female Sexual Dysfunction, Sexual dysfunction, Surveys/questionnaires Comments closed
More about Flibanserin
You'll remember a couple of weeks ago there was a lot of media hype around the development of a new drug - Flibanserin- aimed at tackling 'Hypoactive Sexual Desire Disorder' in women.
There's been a few developments in the media coverage of the drug over the past fortnight so I thought it was a good time to catch up with some of the issues addressed.
Also posted in Desire, Female Sexual Dysfunction, Medicalisation Comments closed
New trials of female sexual dysfunction drug (Flibanserin) will be reported this week
Here's the back plot to this latest drug for female sexual dysfunction and questions you should be asking about Flibanserin.
Also posted in Activism and Open Access, Desire, Female Sexual Dysfunction, Intercourse, Intrinsa, Journalism, Medicalisation, Orgasm, PT141, RCTs, Research, Sexual dysfunction, Viagra Comments closed





A little bit more on the medicalisation of sex